aap Implantate AG
aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
aap Implantate AG
We refer to the voting rights announcement pursuant to sections 33 et seq. WpHG of Axxion S.A. dated November 4, 2021. Axxion S.A. exceeded the threshold of 10% of the voting rights from shares on November 4, 2021. As a result, Axxion S.A. issued a corresponding voting rights announcement pursuant to sections 33 et seq. WpHG. In this context, Axxion S.A. informed us of the following on November 5, 2021 pursuant to section 43 WpHG: 1. The purpose of the investment is to generate trading profits for the invested mutual fund. 2. Depending on the share price and operating performance over the next 12 months, the acquisition of additional shares and sales cannot be ruled out. 3. The company does not seek to influence the composition of administrative, management or supervisory bodies. 4. No significant change in the capital structure of the Company, in particular with regard to the ratio of equity and debt financing and the dividend policy, is envisaged. The funds used to acquire the voting rights are equity of the investing investment funds.
05.11.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | aap Implantate AG |
Lorenzweg 5 | |
12099 Berlin | |
Germany | |
Internet: | www.aap.de |
End of News | DGAP News Service |